放射治疗诱导的铁化用于癌症治疗
Giovanni L Beretta1, Nadia Zaffaroni1
1Molecular Pharmacology Unit, Department of Experimental Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.
Frontiers in molecular biosciences
|June 30, 2023
概括
铁灭,细胞死亡过程,是癌症治疗的关键. 将放射治疗与小分子或纳米医学相结合,有望克服癌症生长和抵抗.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 纳米医学是一种纳米医学.
背景情况:
- 铁亡是一种依赖于铁的细胞死亡途径,对癌症治疗至关重要.
- 放射治疗可以诱导铁亡,有助于瘤抑制.
- 将放射治疗与其他药物结合使用可能会提高癌症治疗的疗效.
研究的目的:
- 审查铁亡机制及其与放射治疗的相互作用.
- 讨论最近关于将放射治疗与小分子和纳米医学结合用于癌症治疗的发现.
主要方法:
- 关于铁亡机制的文献综述.
- 对结合放射治疗与小分子和纳米医学的临床前研究的分析.
主要成果:
- 铁和放射疗法共享相互连接的细胞通路.
- 放射治疗与小分子或纳米医学的结合证明了对抗癌症生长的有效性.
- 这些组合显示出克服对传统治疗方法耐药性的潜力.
结论:
- 铁亡是癌症治疗的重要目标,特别是与放射治疗相结合时.
- 放射治疗诱导的铁亡,通过小分子或纳米药物增强,为瘤抑制和克服抵抗提供了一个有前途的策略.
相关概念视频
Necrosis
4.6K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.6K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K


